Identification of novel protein kinase receptor type 2 inhibitors using pharmacophore and structure-based virtual screening (2018)
- Authors:
- Autor USP: SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP
- Unidade: FCFRP
- DOI: 10.3390/molecules23020453
- Subjects: ARTRITE REUMATOIDE; ANTI-INFLAMATÓRIOS
- Keywords: RIPK2; Ponatinib; WEHI-345; Virtual screening; Rheumatoid arthritis; Anti-inflammatory
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
CRUZ, Josiane V. et al. Identification of novel protein kinase receptor type 2 inhibitors using pharmacophore and structure-based virtual screening. Molecules, v. 23, n. 2, 2018Tradução . . Disponível em: https://doi.org/10.3390/molecules23020453. Acesso em: 16 nov. 2024. -
APA
Cruz, J. V., Neto, M. F. A., Silva, L. B., Ramos, R. da S., Costa, J. da S., Brasil, D. S. B., et al. (2018). Identification of novel protein kinase receptor type 2 inhibitors using pharmacophore and structure-based virtual screening. Molecules, 23( 2). doi:10.3390/molecules23020453 -
NLM
Cruz JV, Neto MFA, Silva LB, Ramos R da S, Costa J da S, Brasil DSB, Lobato CC, Costa GV da, Bittencourt JAHM, Silva CHT de P da, Leite FHA, Santos CBR. Identification of novel protein kinase receptor type 2 inhibitors using pharmacophore and structure-based virtual screening [Internet]. Molecules. 2018 ; 23( 2):[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/molecules23020453 -
Vancouver
Cruz JV, Neto MFA, Silva LB, Ramos R da S, Costa J da S, Brasil DSB, Lobato CC, Costa GV da, Bittencourt JAHM, Silva CHT de P da, Leite FHA, Santos CBR. Identification of novel protein kinase receptor type 2 inhibitors using pharmacophore and structure-based virtual screening [Internet]. Molecules. 2018 ; 23( 2):[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/molecules23020453 - RNA interference in drug discovery
- Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design
- Planejamento racional de inibidores de enzimas-alvo aplicado a diferentes doenças: modelagem, síntese, bioquímica e QSAR
- Potential inhibitors of the enzyme acetylcholinesterase and juvenile hormone with insecticidal activity: study of the binding mode via docking and molecular dynamics simulations
- Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase
- General aspects of lead finding and optimization in drug discovery
- Molecular dynamics, density functional theory, pharmacophore modeling, molecular interaction fields and ADME/tox investigation of novel bioactive compounds interacting with CDK2 surfaces
- Pharmacophore-based drug design of novel potential tau ligands for Alzheimer's disease treatment
- Toward of safer phenylbutazone derivatives by exploration of toxicity mechanism
- Dinâmica molecular: teoria e aplicações em planejamento de fármacos
Informações sobre o DOI: 10.3390/molecules23020453 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002952500.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
